---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-310731"
form_type: "8-K"
ticker: "EYPT"
cik: "0001314102"
company_name: "EyePoint, Inc."
filed_at: "2025-12-08T23:59:59+00:00"
generated_at: "2026-05-16T13:55:54.359664+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# EyePoint Pharmaceuticals renamed to EyePoint, Inc. effective Dec 8, 2025

## Summary
- Corporate name changed to EyePoint, Inc.; no change to ticker symbol EYPT.
- Name change effective December 8, 2025; CUSIP remains 30233G209.
- Stockholder rights unaffected; common stock continues on Nasdaq under EYPT.
- No other amendments to certificate or by-laws beside the name change.

## SEC filing metadata
- accession: 0001193125-25-310731
- form_type: 8-K
- ticker: EYPT
- cik: 0001314102
- company_name: EyePoint, Inc.
- filed_at: 2025-12-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314102/000119312525310731/0001193125-25-310731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314102/000119312525310731/d60563d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-310731
- JSON: https://secwatch.observer/filing/0001193125-25-310731.json
- Plain text: https://secwatch.observer/filing/0001193125-25-310731.txt

## Key facts
- Governance Changes
  EyePoint, Inc.: On December 8, 2025, the Company filed a certificate of amendment to its Certificate of Incorporation to change its name from 'EyePoint Pharmaceuticals, Inc.' to 'EyePoint, Inc.', effective December 8, 2025 (effective 2025-12-08).
  - Change: charter amendment
  - Effective: 2025-12-08
  source text: On December 8, 2025, EyePoint, Inc. (the “Company”) filed a certificate of amendment (the “Certificate of Amendment”) to its Certificate of Incorporation, as amended, solely to change the Company’s name from “EyePoint Pharmaceuticals, Inc.” to “EyePoint, Inc.” The name change became effective on December 8, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1314102/000119312525310731/0001193125-25-310731-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.